16,839 Shares in Establishment Labs Holdings Inc. $ESTA Purchased by Legal & General Group Plc

Legal & General Group Plc bought a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 16,839 shares of the company’s stock, valued at approximately $1,445,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Establishment Labs by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock valued at $2,335,000 after acquiring an additional 9,557 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Establishment Labs by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock valued at $1,105,000 after purchasing an additional 299 shares during the last quarter. WINTON GROUP Ltd purchased a new position in shares of Establishment Labs during the second quarter valued at about $651,000. Nebula Research & Development LLC increased its holdings in shares of Establishment Labs by 27.9% in the second quarter. Nebula Research & Development LLC now owns 16,214 shares of the company’s stock worth $692,000 after purchasing an additional 3,538 shares during the last quarter. Finally, Sei Investments Co. boosted its stake in Establishment Labs by 13.3% during the second quarter. Sei Investments Co. now owns 48,428 shares of the company’s stock valued at $2,068,000 after buying an additional 5,668 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

NASDAQ:ESTA opened at $74.29 on Monday. The company has a quick ratio of 2.52, a current ratio of 3.84 and a debt-to-equity ratio of 12.11. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of -56.71 and a beta of 1.05. The firm has a 50 day moving average of $83.45 and a 200 day moving average of $74.89. Establishment Labs Holdings Inc. has a 52 week low of $36.53 and a 52 week high of $97.59.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The firm had revenue of $67.54 million for the quarter, compared to analyst estimates of $65.79 million. During the same period in the prior year, the firm posted ($0.57) EPS. The business’s revenue was up 31.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. BTIG Research reaffirmed a “buy” rating and set a $103.00 price objective on shares of Establishment Labs in a report on Tuesday, September 1st. Canaccord Genuity Group set a $105.00 price objective on shares of Establishment Labs in a research report on Thursday, August 6th. Needham & Company LLC increased their price objective on shares of Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research note on Wednesday, June 24th. Finally, Citigroup upgraded shares of Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 target price on the stock in a research report on Thursday, August 13th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $100.25.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.